Pennant Group to Participate in the 2025 Oppenheimer Annual Healthcare Conference
EAGLE, Idaho, March 07, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2025.
Brent Guerisoli, Chief Executive Officer, Lynette Walbom, Chief Financial Officer, and Kirk Cheney, Executive Vice President, will participate in a fireside chat on March 18, 2025 at 10:00 a.m. Eastern Time. A live webcast of the event will be accessible at the following address: investor.pennantgroup.com/events-and-presentations.
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 131 home health and hospice agencies and 60 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Contact Information
The Pennant Group, Inc.(208) 506-6100ir@pennantgroup.com
SOURCE: The Pennant Group, Inc.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Those who invested in BrightSpire Capital (NYSE:BRSP) three years ago are up 2.0%
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term BrightSpire Capital, Inc. (NYSE:BRSP) shareholders, since the share price is down 29% in the last three years, falling well short of the market return of around 64%. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. BrightSpire Capital wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually desire strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. In the last three years, BrightSpire Capital saw its revenue grow by 0.5% per year, compound. Given it's losing money in pursuit of growth, we are not really impressed with that. Indeed, the stock dropped 9% over the last three years. If revenue growth accelerates, we might see the share price bounce. But ultimately the key will be whether the company can become profitability. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). Take a more thorough look at BrightSpire Capital's financial health with this free report on its balance sheet. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of BrightSpire Capital, it has a TSR of 2.0% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! BrightSpire Capital shareholders are up 1.5% for the year (even including dividends). Unfortunately this falls short of the market return. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 5% over five years. It may well be that this is a business worth popping on the watching, given the continuing positive reception, over time, from the market. It's always interesting to track share price performance over the longer term. But to understand BrightSpire Capital better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for BrightSpire Capital you should be aware of. Of course BrightSpire Capital may not be the best stock to buy. So you may wish to see this free collection of growth stocks. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
Biological Wastewater Treatment Market Report 2025, with Profiles of Notable Players Veolia, SUEZ, Ecolab, Xylem, Pentair, AECOM, Aquatech, Evoqua Water Technologies, Organica Water & more
The Biological Wastewater Treatment Market offers key opportunities driven by rapid urbanization, industrial expansion, and a global emphasis on sustainable water management. Rising environmental awareness and stringent regulations enhance adoption in regions pressured by water scarcity. Technological integration with AI and IoT for smart management, coupled with demand from sectors like food, pharmaceuticals, and textiles, further boost market potential. Biological Wastewater Treatment Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Biological Wastewater Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to Biological Wastewater Treatment Market was valued at USD 10.01 Billion in 2024 and is expected to reach USD 14.34 Billion by 2030, rising at a CAGR of 6.01%. Market growth is being driven by rapid urbanization, expanding industrial activities, and the global push toward sustainable water management. Biological treatment methods, which utilize microorganisms to degrade organic pollutants, are increasingly favored due to their environmental friendliness, cost-efficiency, and effectiveness in treating both municipal and industrial wastewater. Rising awareness about water pollution and stricter regulations governing effluent discharge are accelerating adoption across regions. Urban growth, especially in emerging economies, is straining existing wastewater systems, creating demand for advanced biological solutions. Meanwhile, industries like food & beverage, pharmaceuticals, chemicals, and textiles are adopting these technologies to meet environmental standards and minimize ecological impact. The combined effect of regulatory pressure, industrial demand, and the global need for clean water positions biological wastewater treatment as a critical solution for sustainable wastewater management. Key Market Drivers: Stringent Environmental Regulations on Effluent Discharge Global environmental policies are increasingly enforcing stricter regulations on the discharge of untreated or inadequately treated wastewater. Countries such as the United States, Canada, Germany, and Japan have implemented stringent standards, where failure to comply can lead to heavy penalties or operational halts. Biological wastewater treatment systems are becoming the preferred solution due to their proven ability to effectively remove biodegradable organic materials and nutrients like nitrogen and phosphorus. These capabilities help industries and municipalities meet regulatory benchmarks efficiently. Regulatory frameworks such as the European Union's Urban Waste Water Treatment Directive require biological treatment for communities exceeding 2,000 population equivalents, prompting broader global adoption. Industrial sectors, including pulp & paper, food & beverage, and textiles, are under increasing pressure to adopt or upgrade biological treatment systems to comply with such mandates and ensure sustainable operations. Key Market Challenges: High Capital and Operational Costs of Advanced Biological Systems Despite their environmental advantages, advanced biological wastewater treatment systems pose significant financial challenges. High initial capital outlays are required for building infrastructure such as aeration tanks and sludge handling units, especially for technologies like Membrane Bioreactors (MBR) and Moving Bed Biofilm Reactors (MBBR). This financial burden is particularly daunting for low-income regions and small-scale operators. Moreover, the ongoing operational expenses - including energy-intensive aeration processes, skilled labor, monitoring systems, and regular maintenance - add to the total cost of ownership. The need for periodic replacement of components like membranes or biofilm media further increases lifecycle costs. These economic constraints hinder widespread adoption, especially where municipal budgets are tight or cost-efficiency takes precedence, often resulting in the continued use of less effective or more environmentally harmful alternatives. Key Market Trends: Integration of AI, IoT, and Automation for Smart Process Management The adoption of digital technologies such as AI, IoT, and automation is transforming biological wastewater treatment into a more intelligent and efficient process. These innovations allow real-time monitoring and autonomous control of critical operations, including aeration, nutrient balance, and sludge management. Smart systems can quickly respond to changes in influent conditions, detect microbial imbalances, and automatically adjust parameters to ensure continuous compliance and optimal performance. AI-driven analytics enable predictive maintenance and help minimize system downtimes. IoT-enabled sensors installed across treatment units provide precise data on parameters like dissolved oxygen, pH, BOD, and ammonia levels. These advancements are being embraced globally, particularly in areas with labor shortages or complex treatment needs. Municipal utilities in Europe and industrial zones in China and India are leading adopters of AI-augmented treatment plants, which enhance reliability, reduce manual intervention, and support long-term sustainability. Key Market Players: Veolia Water Technologies SUEZ Water Technologies & Solutions Ecolab Inc. Xylem Inc. Pentair plc AECOM Aquatech International Evoqua Water Technologies Organica Water Kurita Water Industries Ltd. Key Attributes: Report Attribute Details No. of Pages 185 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $10.01 Billion Forecasted Market Value (USD) by 2030 $14.34 Billion Compound Annual Growth Rate 6.0% Regions Covered Global Report Scope: In this report, the Global Biological Wastewater Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: Biological Wastewater Treatment Market, By Type: Aerobic Anaerobic Biological Wastewater Treatment Market, By End-User Industry: Municipal Industrial Biological Wastewater Treatment Market, By Technology: Suspended Growth Systems Attached Growth Systems Integrated Systems Biological Wastewater Treatment Market, By Application: Effluent Treatment Plants Sewage Treatment Plants Common & Combined Effluent Treatment Plants Biological Wastewater Treatment Market, By Region: North America United States Canada Mexico Europe Germany France United Kingdom Italy Spain South America Brazil Argentina Colombia Asia-Pacific China India Japan South Korea Australia Middle East & Africa Saudi Arabia UAE South Africa For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Biological Wastewater Treatment Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Gen-Z Founder Launches Nebula — The AI Tool for the 32,000 AI Tools
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- With over 400 million people using artificial intelligence tools daily, the market for AI-driven solutions has grown rapidly — now boasting over 32,000 tools worldwide. Yet, despite this exponential growth, most users struggle to discover, compare, or select the right tools for their needs. Addressing this challenge head-on is Nebula, a newly launched AI discovery platform founded by 21-year-old entrepreneur Adrian positions itself as 'the AI tool for AI tools,' offering users a centralized, intelligent, and user-friendly platform to navigate the vast and often fragmented AI landscape. The platform features the world's most extensive database of AI tools, enhanced with verified reviews from trusted sources such as Trustpilot and G2, and a personalized chatbot to assist users in selecting tools tailored to their unique requirements. 'Our mission with Nebula is to make AI tool discovery intuitive and valuable,' said Adrian Nunez, Founder and CEO of Nebula. 'Many users today rely on outdated recommendations or generic online lists. Nebula brings order to the chaos by delivering a curated, modern experience designed to connect the right tools with the right users.'Unlike traditional directories, Nebula's swipe-based interface mirrors the experience of consumer apps, enabling users to engage with AI tool discovery in a more intuitive, familiar way. This design-forward approach caters especially to the growing Gen-Z and millennial user base engaging with AI for content creation, automation, business, and personal productivity. Since its early content rollout, Nebula has already attracted over 6,000 YouTube subscribers, with videos averaging 30,000+ views — building a strong community even prior to its full-scale launch. The platform is free to use for both users and developers. Nebula's monetization is driven by affiliate partnerships, earning commissions when users sign up for recommended tools. This model ensures that the platform's incentives remain aligned with users' interests, promoting only high-quality, vetted AI tools. 'Nebula is not just another AI tool — it's the infrastructure to help people access the entire AI ecosystem,' Nunez added. 'Whether you're a student, a freelancer, or a business owner, our goal is to be the go-to platform where you unlock AI's full potential.' Nebula is now live at . Users are invited to explore the database, engage with the AI-powered chatbot, and join a rapidly growing community of AI enthusiasts, creators, and professionals. Media Contact: Company Name: Nebula Name: Adrian NunezEmail: adrian@ Website: Disclaimer: This press release is provided by the Nebula Inc.. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. Photos accompanying this announcement are available at: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
